NTP42

Cat. No.: 0225LY-0922

Appearance: Solid

Purity: ≥99%

Identity: Confirmed by NMR, and HPLC.

Size:

INQUIRY Datasheet MSDS

Add to basket

Product Overview

Description: NTP42 is an antagonist targeting the thromboxane A2 (TXA2) receptor, with a measured IC50 of 3.278 nM.

Synonym: 2055599-51-2; N-(tert-Butylcarbamoyl)-5-cyano-2-((4'-(difluoromethoxy)-[1,1'-biphenyl]-3-yl)oxy)benzenesulfonamide; NTP-42; 1-tert-butyl-3-[5-cyano-2-[3-[4-(difluoromethoxy)phenyl]phenoxy]phenyl]sulfonylurea; Benzenesulfonamide, 5-cyano-2-((4'-(difluoromethoxy)(1,1'-biphenyl)-3-yl)oxy)-N-(((1,1-dimethylethyl)amino)carbonyl)-; N-(tert-Butylcarbamoyl)-5-cyano-2-((4'-(difluoromethoxy)-(1,1'-biphenyl)-3-yl)oxy)benzenesulfonamide; 1-tert-butyl-3-(5-cyano-2-(3-(4-(difluoromethoxy)phenyl)phenoxy)phenyl)sulfonylurea

CAS No.: 2055599-51-2

Compound CID: 124147085

Formula: C₂₅H₂₃F₂N₃O₅S

Formula Weight: 515.53

Specification

Relative Density: 1.39 g/cm³

Stability: 3 years in powder form.

Storage: Storage at -20°C.

Applications: NTP42 can be used in respiratory research to evaluate its potential as an antagonist for the thromboxane prostanoid receptor in pulmonary hypertension.